Cross-Over Evaluation of Two Lubricating Eye Drops

Sponsor

Innovative Medical (Industry)

Overall Status

Completed

CT.gov ID

NCT00493662

Collaborator

(none)

Location

Study Details

Study Description

Brief Summary

To evaluate the efficacy of two lubricating eye drops for the treatment of dry eye signs and symptoms.

Condition or Disease	Intervention/Treatment	Phase
Dry Eye	Drug: Polyethylene Glycol 400 0.4% Drug: Propylene Glycol 0.3% Drug: 0.15% sodium Hyaluronate Drug: sodium chloride Drug: sodium phosphate monobasic	Phase 4

Study Design

Study Type:

Interventional

Allocation:

Randomized

Intervention Model:

Crossover Assignment

Masking:

Single

Outcome Measures

Primary Outcome Measures

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Inclusion Criteria:

Patients 18 yrs or older
Males or females
Any race or ethnic background
Patients with present ocular surface discomfort and a SESoD score of at least 2

Exclusion Criteria:

Corneal refractive surgery within 6 months of this study.
Contact lens use on day of examination.
Corneal ectasia.
Current use of Restasis

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Hazleton Eye Specialists	Hazleton	Pennsylvania	United States	18202

Sponsors and Collaborators

Innovative Medical

Investigators

Principal Investigator: Tom Kislan, OD, Hazleton Eye Specialists

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

, ,

ClinicalTrials.gov Identifier:

NCT00493662

Other Study ID Numbers:

5310

First Posted:

Jun 28, 2007

Last Update Posted:

Jan 15, 2008

Last Verified:

Jan 1, 2008

Additional relevant MeSH terms:

Dry Eye Syndromes

Hyaluronic Acid

Study Results

No Results Posted as of Jan 15, 2008